Malignant Peritoneal Mesothelioma: Prognostic Factors and Oncologic Outcome Analysis-Reference-Cited by-同舟云学术

Malignant Peritoneal Mesothelioma: Prognostic Factors and Oncologic Outcome Analysis

Published:2013-12-10 Issue:4 Volume:21 Page:1159-1165
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Magge Deepa,Zenati Mazen S.,Austin Frances,Mavanur Arun,Sathaiah Magesh,Ramalingam Lekshmi,Jones Heather,Zureikat Amer H.,Holtzman Matthew,Ahrendt Steven,Pingpank James,Zeh Herbert J.,Bartlett David L.,Choudry Haroon A.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/s10434-013-3358-y.pdf

Reference33 articles.

1. Munkholm-Larsen S, Cao CQ, Yan TD. Malignant peritoneal mesothelioma. World J Gastrointest Surg. 2009;1:38–48.

2. Price B, Ware A. Mesothelioma trends in the United States: an update based on Surveillance, Epidemiology, and End Results Program data for 1973 through 2003. Am J Epidemiol. 2004;159:107–12.

3. Yan TD, Welch L, Black D, Sugarbaker PH. A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma. Ann Oncol. 2007;18:827–34.

4. Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol. 2003;21:2636–44.

5. van Meerbeeck JP, Gaafar R, Manegold C, Van Klaveren RJ, Van Marck EA, Vincent M, et al. Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada. J Clin Oncol. 2005;23:6881–9.

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consensus Guideline for the Management of Patients with Peritoneal Mesothelioma;2024-04-13

2. A Forgotten Disease - Peritoneal Mesothelioma in an Older Adult;INT J GERONTOL;2024

3. Peritoneales Mesotheliom und Pseudomyxoma peritonei;best practice onkologie;2024-01-22

4. Organoids derived from patients provide a new opportunity for research and individualized treatment of malignant peritoneal mesothelioma;Molecular Cancer;2024-01-10

5. Updates on grading mesothelioma;Histopathology;2023-10-23